Pacific Biosciences of California Inc PACB
๐ Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2010-10-27 |
| Shares Out. | 310,600,000 |
| Website | pacb.com/ โ |
| Phone | 13026365400 |
| Employees | 485 |
| Revenue | $39.0M |
| Gross Profit | $12.6M |
| Net Income | -$44.7M |
| Free Cash Flow | -$123.4M |
| Total Assets | $751.9M |
| Total Liabilities | $785.1M |
| Equity | -$33.2M |
About Pacific Biosciences of California Inc
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Pacific Biosciences of California Inc is a publicly traded company under the ticker symbol PACB on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
14 analysts (2026-09-01)

